EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Multi‐Omics Profiling to Characterize Molecular Subtypes and Reveal Potential Therapeutic Strategies for Colorectal Cancer

Xin Guo, Saisai Tian, Xinxing Li, Hongwei Zhang, Anqi Wang, Yan Jin, Ce Bian, Jiayi Lin, Sanhong Liu, Min Tang, Lijun Zhang, Xin Luan und 2 weitere

MedComm · 2025-12 · 6 (12)

DOI: 10.1002/mco2.70492 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm, online erschienen am 08.12.2025. Verfasst von Xin Guo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Chinese Medicine Chemical Biology Institute of Interdisciplinary Integrative Medicine Research and Shuguang Hosp…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Rising-Star Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a complex and heterogeneous disease with limited effective treatment options. To investigate the molecular features and potential therapeutic strategies for CRC patients, including both early‐onset colorectal cancer (EOCRC) and late‐onset colorectal cancer (LOCRC) cases, a comprehensive multi‐omics approach was employed. Whole exome sequencing (WES), RNA sequencing (RNA‐seq), and proteomic and phosphoproteomic profiling were performed on paired tumor and normal adjacent tissue (NAT) from 144 CRC patients, totaling 672 samples. Three distinct molecular subtypes were identified, each exhibiting unique clinical prognoses and molecular characteristics. The S_I subtype was associated with the worst prognosis and a greater prevalence of EOCRC. Moreover, it exhibited a higher stromal score, characterized by increased infiltration of fibroblasts, mesenchymal stem cells, and adipocytes, when compared with the S_II and S_III subtypes. Additionally, the S_II subtype showed a higher immune score. Drug testing using cell lines and patient‐derived three‐dimensional (3D) bioprinted models revealed that S_I tumors were more responsive to Alisertib, suggesting subtype‐specific therapeutic potential. Our study characterized the multi‐omics landscape of CRC, offering critical insights into its molecular heterogeneity. These findings enhance our understanding of the molecular mechanisms underlying CRC and contribute to the development of personalized treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancer (CRC)molecular subtypemulti‐omicstherapeutic strategy

Autor:innen und Institutionen

  • Shanghai Frontiers Science Center of Chinese Medicine Chemical Biology Institute of Interdisciplinary Integrative Medicine Research and Shuguang Hospital Shanghai University of Traditional Chinese Medicine Shanghai Chin…
  • School of Pharmacy Shanghai Jiao Tong University Shanghai China.
  • School of Pharmacy Naval Medical University Shanghai China.
  • Department of Gastrointestinal Surgery Tongji Hospital Tongji University School of Medicine Shanghai China.
  • Division of Colorectal Surgery Changzheng Hospital Naval Medical University Shanghai China.
  • State Key Laboratory For Quality Ensurance and Sustainable Use of Dao-di Herbs Institute of Medicinal Plant Development Chinese Academy of Medical Science and Peking Union Medical College Beijing China.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Rising-Star Program

Zitieren

APA

Guo, X., Tian, S., Li, X., Zhang, H., Wang, A., Jin, Y., Bian, C., Lin, J., Liu, S., Tang, M., Zhang, L., Luan, X., Zhou, H., & Zhang, W. (2025). Integrated Multi‐Omics Profiling to Characterize Molecular Subtypes and Reveal Potential Therapeutic Strategies for Colorectal Cancer. MedComm, 6(12). https://doi.org/10.1002/mco2.70492

Vancouver

Guo X, Tian S, Li X, Zhang H, Wang A, Jin Y, et al. Integrated Multi‐Omics Profiling to Characterize Molecular Subtypes and Reveal Potential Therapeutic Strategies for Colorectal Cancer. MedComm. 2025;6(12). doi:10.1002/mco2.70492

BibTeX
@article{Guo2025,
  author = {Guo, Xin and Tian, Saisai and Li, Xinxing and Zhang, Hongwei and Wang, Anqi and Jin, Yan and Bian, Ce and Lin, Jiayi and Liu, Sanhong and Tang, Min and Zhang, Lijun and Luan, Xin and Zhou, Haiyang and Zhang, Weidong},
  title = {Integrated Multi‐Omics Profiling to Characterize Molecular Subtypes and Reveal Potential Therapeutic Strategies for Colorectal Cancer},
  journal = {MedComm},
  year = {2025},
  volume = {6},
  number = {12},
  doi = {10.1002/mco2.70492}
}
Kostenlos starten →